Nothing to Sneeze At

According to a press release, Trimel, a Canadian pharmaceutical company, is moving forward with clinical trials on Tefina, a proposed treatment for female anorgasmia . The testosterone-based treatment is delivered nasally, as "a bioadhesive 'no touch' intranasal low-dose gel formulation of testosterone."

I read about this through the New View Campaign, which reminds folks that this is only the most recent in a series of drugs taken too quickly through trials to the FDA, only to be turned back...